MilliplexCatID.MKI2MAG-94K-03.MouseKidne

Code: MKI2MAG-94K-03 D2-231

Application

Analytes: Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, Osteopontin (OPN) Recommended Sample type: urine Recommended Sample dilution: 1:1,000 Assay Run Time: over...


read more

Your Price
€2,435.80 EACH
€2,996.03 inc. VAT

Application

Analytes: Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, Osteopontin (OPN) Recommended Sample type: urine Recommended Sample dilution: 1:1,000 Assay Run Time: overnight Research Category: Toxicity

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

Design your multiplex kit by choosing available analytes within this panel.

General description

Maintenance of physiological balance in the body is attributed in part to normal kidney function. An altered kidney function due to injury, drug toxicity or kidney failure may be life threatening. There are multiple risk factors for kidney injury including age, hypertension, diabetes mellitus, heart failure and liver failure. On the other hand, drug induced damage to the kidney results from drug excretion. Traditional markers for assessing renal toxicity, such as blood urea nitrogen (BUN) and serum creatinine, are insensitive and non-specific. Although both are direct measurements of renal function, increases in serum concentrations of these biomarkers occur only after substantial renal injury. Specificity and earlier detection of kidney injury is vital. For improved detection of acute nephrotoxicity, a panel of novel urinary kidney biomarkers has been identified and validated for preclinical studies in relevant animal species. We provide valuable research assays to investigate multiple biomarkers of kidney injury in mouse urine samples using the Luminex® xMAP® instrument platform. The MILLIPLEX® Mouse Kidney Injury Bead Panel 2 contains all the components necessary to measure the following five biomarkers in any combination using Luminex® xMAP® technology: Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, Osteopontin (OPN). The kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 urine samples in duplicate. Panel Type: Toxicity

Legal Information

xMAP is a registered trademark of Luminex Corp

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Sensitivity: Please see kit protocol for individual assay sensitivities.

Please contact Technical Service for linearity of dilution.

Packaging

Everything you need in a single kit.

Specificity

There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Storage and Stability

Recommended storage for kit components is 2 - 8°C.

assay rangestandard curve range: 0.05-50 ng/mL(Cystatin C), accuracy: 90-99%, standard curve range: 0.005-5 ng/mL(Lipocalin-2/NGAL), sensitivity: 0.005-0.190 ng/mL(MinDC+2SD), standard curve range: 0.01-10 ng/mL(Osteopontin (OPN)), standard curve range: 0.04-40 ng/mL(EGF), standard curve range: 0.2-250 ng/mL(Clusterin)
detection methodfluorometric (Luminex xMAP)
manufacturer/tradenameMilliplex®
Quality Level200
shipped inwet ice
species reactivitymouse
technique(s)multiplexing: suitable
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.